Approval · Notice of Compliance 12273 · 2011
ANZEMET: Notice of Compliance 12273
Issued April 18, 2011
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 12273
- Date
- April 18, 2011
- Company
- Sanofi-Aventis Canada Inc.Toronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Other
- Reason
- Removal of intravenous injection dosage form
- Therapeutic class
- Antiemetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ANZEMET | Not yet assigned | — |
Medicinal ingredients
- DOLASETRON MESYLATE 50 MG per TAB
- DOLASETRON MESYLATE 100 MG per TAB